Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms.

Deng, Xunwei; Hou, Jingyuan; Deng, Qiaoting; Zhong, Zhixiong

Deng, Xunwei; Hou, Jingyuan; Deng, Qiaoting; Zhong, Zhixiong.

Afiliación

Deng X; Department of Research Experimental Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-Sen University, No. 63 Huangtang Road, Meijiang District, Meizhou, 514031, People's Republic of China.
Hou J; Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou, People's Republic of China.
Deng Q; Department of Research Experimental Center, Meizhou People's Hospital (Huangtang Hospital), Meizhou Hospital Affiliated to Sun Yat-Sen University, No. 63 Huangtang Road, Meijiang District, Meizhou, 514031, People's Republic of China.
Zhong Z; Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou, People's Republic of China.

World J Surg Oncol ; 18(1): 321, 2020 Dec 06.

Article en En | MEDLINE | ID: mdl-33280607

Asunto(s)

Neoplasias Colorrectales; Dihidrouracilo Deshidrogenasa (NADP); Antimetabolitos Antineoplásicos/uso terapéutico; Neoplasias Colorrectales/tratamiento farmacológico; Neoplasias Colorrectales/genética; Dihidrouracilo Deshidrogenasa (NADP)/genética; Fluorouracilo; Genotipo; Gutatión-S-Transferasa pi/genética; Humanos; Oxaliplatino; Pronóstico

Palabras clave

Chemotherapy toxicity; DPYD; GSTP1; Gene polymorphism; Hakka population

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Dihidrouracilo Deshidrogenasa (NADP) Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: World J Surg Oncol Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google